These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 9349577

  • 1. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases.
    Watanabe M, Amino N, Hochito K, Watanabe K, Kuma K, Iwatani Y.
    Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis.
    Okumura M, Hidaka Y, Kuroda S, Takeoka K, Tada H, Amino N.
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1757-60. PubMed ID: 9177377
    [Abstract] [Full Text] [Related]

  • 4. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
    Matsubayashi S, Akasu F, Kasuga Y, Snow K, Keystone E, Volpé R.
    Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
    [Abstract] [Full Text] [Related]

  • 5. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis.
    Bermann M, Magee M, Koenig RJ, Kaplan MM, Arscott P, Maastricht J, Johnson J, Baker JR.
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460
    [Abstract] [Full Text] [Related]

  • 6. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
    Chan JY, Walfish PG.
    Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
    [Abstract] [Full Text] [Related]

  • 7. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
    Chan JY, Walfish PG.
    J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
    [Abstract] [Full Text] [Related]

  • 8. Serum concentration of soluble Fas in patients with autoimmune thyroid diseases.
    Shimaoka Y, Hidaka Y, Okumura M, Takeoka K, Tada H, Amino N.
    Thyroid; 1998 Jan; 8(1):43-7. PubMed ID: 9492152
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease.
    Mori H, Amino N, Iwatani Y, Asari S, Izumiguchi Y, Kumahara Y, Miyai K.
    J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751
    [Abstract] [Full Text] [Related]

  • 12. Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease.
    Bogner U, Schleusener H, Wall JR.
    J Clin Endocrinol Metab; 1984 Oct; 59(4):734-8. PubMed ID: 6548225
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.
    Okamoto Y, Hamada N, Saito H, Ohno M, Noh J, Ito K, Morii H.
    J Clin Endocrinol Metab; 1989 Apr; 68(4):730-4. PubMed ID: 2921308
    [Abstract] [Full Text] [Related]

  • 15. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
    Yuan S, Yu N, Gao Y, Huang W, He Y, Dong B, Lu G, Li M, Cai X, Peng D, Wang Y, Li T, Huang Y, Gao Y, Guo X, Shi B.
    Zhonghua Yi Xue Za Zhi; 2014 Jan 14; 94(2):110-4. PubMed ID: 24721350
    [Abstract] [Full Text] [Related]

  • 16. Natural killer cell activity in patients with Graves' disease and Hashimoto's thyroiditis.
    Wenzel BE, Chow A, Baur R, Schleusener H, Wall JR.
    Thyroid; 1998 Nov 14; 8(11):1019-22. PubMed ID: 9848716
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases.
    Mariotti S, Caturegli P, Barbesino G, Marinò M, Del Prete GF, Chiovato L, Tonacchera M, De Carli M, Pinchera A.
    Clin Endocrinol (Oxf); 1992 Nov 14; 37(5):415-22. PubMed ID: 1486691
    [Abstract] [Full Text] [Related]

  • 19. Hashimoto's thyroiditis following Graves' disease.
    Umar H, Muallima N, Adam JM, Sanusi H.
    Acta Med Indones; 2010 Jan 14; 42(1):31-5. PubMed ID: 20305330
    [Abstract] [Full Text] [Related]

  • 20. Evidence for thyroid antigen-reactive T lymphocytes infiltrating the thyroid gland in Graves' disease.
    Tötterman TH, Andersson LC, Häyry P.
    Clin Endocrinol (Oxf); 1979 Jul 14; 11(1):59-68. PubMed ID: 391444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.